EU Drug Market: MDMA Retail markets www euda.europa.eu

Given the option, it is clear that people who use MDMA and other drugs will embrace harm reduction approaches, and support their development. Harm reduction is not a principle that policy makers will need to force upon people who use MDMA or other drugs in nightlife and party settings. Significant numbers of people not only like MDMA’s effects and are willing to take known risks (health and legal) to enjoy them, but they seem to prefer it to most available substitutes. Perhaps most obviously it demonstrates, yet again, the futility of putting enforcement, targeting either people who use or supply, at the forefront of the policy response to drugs. The EMCDDA also reported in 2019 that ‘transactions involving quantities of MDMA tablets just click the up coming post indicative of the middle level of the market account for more than double the revenue of sales of retail-level quantities’.
MDMA rarely cited as a reason for entering drug treatment in Europe
Consumers in the Netherlands will typically pay EUR 4.50 per tablet but, as stated above, prices may reach as high as EUR 19 just click the up coming post per tablet in some European countries, and more in other regions of the world. According to Dutch Police, these tablets are sold to distributors at EUR 0.59 per unit (2022 values), who in turn re-sell them at EUR 1.78 each (for quantities above 99 tablets). The subsequent drop in MDMA content in tablets since 2019 does not appear to have been accompanied by a significant drop in price. In 2021, adult respondents to the EWSD reported paying a median of EUR 7.20 per ecstasy tablet and a median of EUR 37.40 per gram for MDMA powder. (a) In clinical trials, doses of MDMA capable of producing subjective effects vary from 1.5 to 1.7 mg/kg of body weight, or approximately 105 to 119 milligrams for a 70-kilogram individual.
Reporting countries
In the period from 2019 to 2023, caffeine, 4-CMC (4), amphetamine, cocaine and MDA were the adulterants most commonly found in MDMA samples (tablets and powders/crystals) submitted to drug-checking organisations belonging to the TEDI network. A number of substances can also be sold as MDMA, in what is sometimes called mis-selling or adulteration by substitution – whereby another substance is passed off as MDMA to the consumer. Again, these data should be interpreted with caution and not necessarily be seen as statistically representative of the market as a whole. Crystal MDMA appeared on the European market at that time, as a response to a fall in consumer confidence due to concerns about the low quality of ecstasy. However, adulteration is commonplace, and therefore these tablets may contain a variety of substances in addition to, or instead of, MDM


According to survey data, the two largest MDMA consumer markets per capita in the European Union are the Netherlands and Ireland, with 6 % or more people aged 15 to 34 reporting to have consumed MDMA in the last year. While a slight decrease in price was observed in 2022 for ecstasy tablets, this just click the up coming post may not be statistically significant or sustained in the coming years. In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing). For countries reporting data in 2022, a considerable retail price range was observed, with prices per ecstasy tablet ranging from EUR 4 to EUR 19 (mean) and prices of MDMA powder from EUR 6 to EUR 50 per gram. Occasionally, tablets containing 250 milligrams or more of MDMA are encountered on EU drug markets.
Da

While a slight decrease in price was observed in 2022 for ecstasy tablets, this may not be statistically significant or sustained in the coming years. In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing). For countries reporting data in 2022, a considerable retail price range was observed, with prices per ecstasy tablet ranging from EUR 4 to EUR 19 (mean) and prices of MDMA powder from EUR 6 to EUR 50 per gram. Occasionally, tablets containing 250 milligrams or more of MDMA are encountered on EU drug markets. This trend may be a combination of the scheduling of PMK glycidate, and a reduction in demand for MDMA during the COVID-19 pandemic, and is in line with the changes observed in the adulteration of ecstasy tablets (see Section Ecstasy adulteration is responsive to market pressures). This means that the ratio of MDMA to fillers (excipients) in the mixtures used to make ecstasy tablets did not increase over this time period.

MDMA, due to its psychoactive effects and potential for misuse, is a substance often tested for in various drug screening processes. MDMA, commonly known as Ecstasy or Molly, is a psychoactive synthetic drug that just click the up coming post affects users’ emotions. MDMA causes these neurotransmitters to be released from their storage sites in neurons result in increased brain activity. MDMA also known by the street name of "ecstasy" is a synthetic drug with both stimulant and hallucinogenic properties. Poppi is a new museum dedicated to retelling the story about drugs.